Cellular and Molecular Biology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Instructions for Authors

1. All papers and articles should be submitted EXCLUSIVELY in English
The manuscripts have to be submitted as a simple E-mail attachment to Professor Wegmann at After this step and after acceptance of the paper from Prof. Wegmann, the author has to find by his own two Peer Reviewers, one obligatorily an American and the second an European or an Asian. The author has to submit to Professor Wegmann their names and their full address with the telephone; the fax and the e-mail Once the author has followed and accomplished the principles of the Peer Reviewing (see this chapter) and obtained from both PRs a positive answer he transmits to Professor Wegmann the finally accepted paper, together with the questions and the replies. Thereafter Prof. Wegmann transmits only the paper to OMICS which will give a reference number to the paper and will provide a rapid publication of the article in approximately one month after payment of the fee, which is US $919 or 700 €.
A. Formats for OMICS Group Contributions: OMICS accepts original articles, letters to editors, notes, comments, reviews, abstracts, addendums, announcements, article-commentaries, book reviews, rapid communications, annual meeting abstracts, conference proceedings, calendars, case-reports, corrections, discussions, meeting-reports, news, obituaries, orations, product reviews, hypotheses and analyses.
B. Cover Letter: All submissions should be accompanied by a 500 words or less cover letter briefly stating the significance of the research, agreement of authors for publication, number of figures and tables, supporting manuscripts and supplementary information. Also, include current telephone and fax numbers, as well as postal and e-mail address of corresponding author to maintain communication.
C. Manuscript Title: The title should be limited to 25 words or less and should not contain abbreviations. The title should be a brief phrase describing the contents of the paper.
D. Abstract: The abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. The abstract should summarize the manuscript content in 300 words or less. Standard nomenclature should be used and abbreviations should be avoided. The preferable format should accommodate a description of the study background, methods, results and conclusion. Following the abstract, a list of keywords (3-10) and abbreviations should be included.
1/A Initial indications: The names of the authors of the different articles have to be presented in an alphabetical order and at the same time presenting a number beginning with 1 for the first name. Such a presentation is called ALPHANUMERIC. It has to be STRICTLY respected. First Name(s) should be presented only as initials followed with a point. Any other presentation is sanctioned by an irrevocable REJECTION of the paper. At the end, their address, telephones, e-mails. Their keywords, the running title, the abbreviations from which some are traditional like min, sec, hr, Fig. and ml.
1/B Final indications: Use throughout an uniform style Times New Roman, character 12, double leading out, 0.5 Tabs. For sub and superscript use their respective commands. Do not use spacemen up-and down-shifting. Proofread carefully the final text in order that it is clear, grammatically correct and free of typographical errors. Footnotes should be avoided. Formatting and typography will be handled by OMICS Publishing Group.
2/ Introduction: The introduction should be set to tone the paper by providing a clear statement of the study, the relevant literature on the study subject and the proposed approach or solution. The introduction should be general enough to attract a reader’s attention from a broad range of scientific disciplines.
3/ Results: The results section should provide complete details of the experiment that are required to support the conclusion of the study. The results should be written in the past tense when describing findings in the authors’ experiments. Previously published findings should be written in the present tense. Make sure the parts of the manuscript are in the correct order for the relevant journal before ordering the citations. Results and discussions may be combined or in a separate section. Speculation and detailed interpretation of data should not be included in the results but should be put into the discussion section.
1. Types of references: Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference talks, or papers that have been submitted but not yet accepted should not be cited. All personal communications should be supported by a letter from the relevant authors.
2. Type of referencing: OMICS uses the ALPHANUMERICAL reference system as it has been already recommended initially in the Manuscript (I,1A) arranged STRICTLY alphabetically and numbered. Multiple citations within a single set of brackets should be separated by commas. When there are three or more sequential citations, they should be given as a range. Example: "... now enable biologists to simultaneously monitor the expression of thousands of genes in a single experiment [1,5-7,28]". Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is crucial.

3. Presentation:The three parts of a reference: name of the author(s), text, journal reference have to be placed one under the other and not one behind the other like in other journals.
Any other presentation is rejected.

4. The correct sequence is:

a/ First line : Absolutely all name(s) of the author(s. It is strictly forbidden to use “et al” whereas absolutely all names have to be cited, as numerous they may be.
i/ No comma behind the main name but
ii/ with a point behind each first name
iii/ with “&” before the last name and clearly separated by one interval from the previous name

b/ Second line : That is the line presenting the text of reference , without any abbreviation

c/ Third line : It is that of the internationally correctly abbreviated journal with the volume in fatty underlined characters and i/ with a comma behind the journal and a comma behind the year ii/ with one interval after the journal and after the year

5. Forbidden presentation: It is STRICTLY forbidden to use truncated and incomplete journal references like such from PubMed , which end often with the DOI reference or with ‘in Press” whose use are STRICTLY forbidden in a scientific paper. Only ORIGINAL PAPER are accepted. Consequently it is strictly forbidden to use a DOI as reference, like it is presented in PubMed.The author has to refer to the original reference what naturally costs some consumption of time.
6. Correct examples: which have to be STRICTLY followed and which are valuable as well for journals, books and review series
A. Journals
Augusto C., Lunardin L.O. & Vugman L.
Reduction in rat mesentery mast cell staining after degranulation by protamine. A competititive antagonism.
Cell.Mol.Biol. 1998, 42:357-361.
B. Books
Cohen T., in:
Synaptic Function,
Edelman G.M., Gall W.E. & Cowan W.M. (eds),
John Wiley & Sons, New York, 1999 pp.179-212
C. Reviews Series
Morrison G.M.,
Aspartate kinase, I, II and III from Escherichia coli, in:
Colowick S.P. and Kaplan N.O. (eds), Acadermic Press, New York, 2000, 113:596-599
If any of the components of B and C is under publication it should be written after the town of publication with: “in press, accepted :(month, date, year)
A/ Ordinary tables
1/ Presentation: The tables should be presented clear and easy to read. Not more than 3 tables should be included. Include the tables at the end of the word processor after the figure captions. Use tables as simply as possible. We strongly encourage authors to submit tables as .doc format. Uses tab stops of 0.5 cm and decimal tab stops to line up columns. Do not use neither spaces, nor do table formatting. Don’t use EXCEL. Tables are to be typed double-spaced throughout, including headings and footnotes. Each table should be on a separate page, numbered consecutively in arabic numerals and supplied with a heading and a legend. Tables captions should be placed at the end of the manuscript. Tables have to be referred to at an appropriate point in the main text of the paper.
2/ Methodology: Tables should be self-explanatory without reference to the text. Preferably, the details of the methods used in the experiments should be described in the legend instead of in the text. The same data should not be presented in both table and graph form or repeated in the text. Cells can be copied from an Excel spreadsheet and pasted into a word document, but Excel files should not be embedded as objects.

B/ Tables and Equations as Graphics

1/ Equations: equations should be presented in character 8.5, the rest of the paper character 10.5. One column size is 8.5 cm, long equations should be presented on 2 or more lines, never exceeding the one column size. Behind ( or [ signs: please add one extra space. If an 1/ Equation cannot be encoded in MathML, submit them in TIFF or EPS format as discrete files (i.e., a file containing only the data for one equation).
2. Graphics: Only when tables cannot be encoded as XML/SGML can they be submitted as graphics. If this method is used, it is critical that the font size in all equations and tables is consistent and legible throughout all submissions.
  • Suggested Equation Extraction Method
  • Table Specifications
  • Equation Specifications
The preferred file formats for photographic images are .doc, TIFF and JPEG. If you have created images with separate components on different layers, please send us the Photoshop files.
All images must be at or above intended display size, with the following image resolutions: Line Art 800 dpi, Combination (Line Art + Halftone) 600 dpi, Halftone 300 dpi. See the Image quality specifications chart for details. Image files also must be cropped as close to the actual image as possible.
Use Arabic numerals to designate figures and upper case letters for their parts (Figure 1). Begin each legend with a title and include sufficient description so that the figure is understandable without reading the text of the manuscript. Information given in legends should not be repeated in the text.
Figure legends: These should be typed sequentially in numerical order on a separate rate sheet. The number of figures should be in accordance with the paper length and be be placed at the end of the manuscript. Indicate the preferred placement of each figure in the the word processor. Figures summary, diagram/figure may be included as part of the complementary information (optional).
2. File formats: Authors should submit original hardcopy artwork of high quality and of correct size, as it will appear on the printed journal. That is:
Fullpage size: maximum 17,5 cm (width) x 23 cm
1 column size: maximum 8,5 cm (width) x 23 cm
The preferred red file formats for photographic images are : .doc, TIFF, JPG and EPD and EPS high resolution e-files. Don’t use WORD files. If you have created images with separate components on different layers, please use the Photoshop files. Graphics files must not be imported into the word processor files. All legends should be included in the word processor files. All legends should be at the end included at the end of the word processor file, after the references.

Figure File description: As many colour figures as wished may be published without any any cost.Use cost. Arabic numerals are used to designate figures and upper case letters for their parts. Begin each legend with a title and include sufficient description so that the are understa figures are understandable without reading the text of the manuscript. Information legends tion given in legends should not be repeated in the text.
On the back of each figure lightly indicate with a pencil the author’s name, short me manuscript title, figure number and orientation (arrow indicate up)
1.The research mode: This is an important step of the activity of the author, because contrarily to all other journals who provide Peer Reviewers to their authors, the journal Cellular and Molecular Biology® lets to the author the responsibility and the pleasure to find his own Peer Reviewers.
2. The research cause: This has a deep reason: the topics to be criticized have become so numerous and so diversified that it becomes difficult and often impossible to find the correct Peer Reviewer. And the journal cannot collect and provide an aeropaus full of Peer Reviewers. It is interesting to mention that the journal is contacted by an incredible number of candidates requiring to become Peer Reviewers, over 200 in two years. That comes from the fact that NONE of them has read this web site. But Professor Wegmann has found for some of them another fascinating occupation from what will be presented later on in this journal as a complete report, explaining what has happened with them, how a very small collection of them has been selected and accepted to exert this new occupation.
3. The research principles: It is absolutely evident and admitted that the author who writes the paper knows much better his topic than anybody else. He knows from the literature the authors having worked on the same topic or at least in the same direction. He can consequently ask their advice to ameliorate his paper by criticizing it. That is called PEER REVIEWING. Traditionally it has been observed that TWO Peer Reviewers check much better a paper than one single one, alone Their judgment becomes more equilibrated and favor the obtainment of a paper of quality. This has a repercussion over the entire journal and gives it a fame of excellence. It is not for nothing that 22 Nobel Prize Winners are present in the Editorial Board.
4. The selection of the PR: The first Peer Reviewer is obligatorily an American but the second PR can be a European, an Asian or a south American. But in no any way these PRs can be chosen from the own Laboratory, Institute, Faculty or University. They must be selected from other FOREIGN faculties and preferentially from Faculties and Universities of great reputation whose scientists have world reputation.
5. The research technique: After having chosen both Peer Reviewers (PR) the author sends to each one, on line, a copy with a submission paper (see examples to join) on which the PR places his appreciations. The PR has to send back to the author his comments and questions. The author has to answer the questions and to correct the papers. The PR sends back to the author the replies and the corrected copy. Finally the author makes from both corrected copies one unique example and sends it to Professor Wegmann together with the questions and the answers. Professor Wegmann makes a last control but can submit the paper to a third PR of his choice in case of some problem overseen by both PRs. Finally he sends the corrected paper to OMICS, which at the reception sends a reference number to the author and publishes it as soon as the author has accomplished his financial charges (see AIMS and SCOPES, end of 1st§, VI C, copyright and VI D, processing charges)
6. Duration of a peer rewiewing: A peer reviewing should not take too much time to the PRs: one to two weeks. If it lasts longer, the author has the right to remember to the PR his duty, but with tact and diplomacy, learning him that the publication of the paper is URGENT. Give a reason of this urgency: thesis, obtainment of funds, etc… If the PR fails to answer, take another! If the author has difficulties with a PR, contact Prof.Wegmann ; but it is much better to consult PubMed or MedLine, because it is there where the author can find the most easily his PR!
A.Supplementary Information: All supplementary information is supplied as a single PDF file, where possible. File size should remain within the permitted limits for supplementary information. Images should be a maximum size of 640 x 480 pixels (9 x 6.8 inches at 72 pixels per inch
B. Proofs and Reprints: Electronic proofs will be sent as an e-mail attachment to the corresponding author as a PDF file. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Authors will have free electronic access to the full text (HTML, PDF and XML) of the articles. Authors can freely download the PDF file from which they can print unlimited copies of their articles.
C. Copyright: All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Submission of a manuscript implies that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) and that it is not under consideration for publication elsewhere.

D. Article Processing Charges: As a compensation to the possession of the copyright from the authors  it has to be considered that the publishing house has the right to receive  an indemnity for its activity to publish the paper in order to cover its expenses which are relatively high, having no other resources for this activity. This system has been initiated by the Nobel  Prize Winner VARMUS who had considered that the papers published from the publishing houses and which were owners of the copyright had a too restricted extension in the world and that it was necessary to transfer the copyright to the authors what should have theoretically the consequence that the papers of the authors would receive a much larger diffusion as never before, so that the authors could become able  to  perform  more easily  better investigations.
          This system is still not perfectly well understood and mostly because of the high cost for the authors to publish a paper. But progressively the universities understand better the difficulties of the authors by providing to the scientists higher and more correct subsidies.
             But I let observe  that my journal, the “Cellular and Molecular Biology™” has never, in his 64 years of existence,  requested any right on the copyright and had left to the authors the right to possess it, having not seen in any way a problem with such a situation having permitted them to  make as much reprints as  wished or to let copy any of its papers, the costs having been largely covered by the subscriptions of the journal by the university librarians.
             It has to be known hat my system  will continue  to exist with OMICS and remain  to  be valuable because OMICS has accepted to undertake  a HYBRID publishing, on  one side using the OPEN ACCESS system for individual papers which are charged and on the other side the ancient system with the copyright belonging to the authors when these authors publish papers in a THEME, a speciality of the journal since 1990, which gathers together papers of a same topic obtained from authors who contribute therein under  the direction of a  GUEST EDITOR. This system is FREE of COST and has been developed after the dirty attempt of robbery of my journal by the dutch publishing company ELSEVIER, a not recommendable horribly money greedy company whose behavior towards me was that of the MOST DISHONEST ROBBER company, and that in a SADISTIC MANNER with an ASHAMING manoeuver which I have NEVER FORGIVEN.

E. Common Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. submission of a manuscript implies that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) and that it is not under consideration for publication elsewhere.

The CHARGE for any type of paper is therefore US $919 or 700 €
F. Acknowledgement: This section includes acknowledgment of people, grant details, funds, etc. They are pleased to maintain clear titles namely headings, subheadings an so on.
G. Electronic Journal Articles and Programming Utilities: commonly it is like :
OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version